Canopy Growth

Canopy Growth R&D per Employee

The R&D Spending per Employee of Canopy Growth (WEED.TO) as of Nov 6, 2026 is 870.20 CAD. In the previous year, R&D Spending per Employee was 1,463.34 CAD — a change of -40.53% (lower).

R&D per Employee

870.20CAD

YoY

-40.53%

Last updated:

R&D Spending per Employee of Canopy Growth is 2025 870.20 CAD. R&D Spending per Employee of Canopy Growth was 2024 1,463.34 CAD. It decreases by -40.53% lower compared to the previous year.

The Canopy Growth R&D per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

R&D per Employee
Date
R&D per Employee
Jan 1, 2018
461.12 CAD
Jan 1, 2019
4,835.93 CAD
Jan 1, 2020
19,616.63 CAD
Jan 1, 2021
18,274.20 CAD
Jan 1, 2022
10,238.34 CAD
Jan 1, 2023
6,892.42 CAD
Jan 1, 2024
1,463.34 CAD
Jan 1, 2025
870.20 CAD
The Canopy Growth R&D per Employee history
YEARR&D per EmployeeYoY
870.20CAD-40.53%
1,463.34CAD-78.77%
6,892.42CAD-32.68%
10,238.34CAD-43.97%
18,274.20CAD-6.84%
19,616.63CAD+305.64%
4,835.93CAD+948.73%
461.12CAD+79.38%
257.06CAD+12.34%
228.82CAD+237.55%
67.79CAD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Canopy Growth Stock analysis

What does Canopy Growth do? Canopy Growth Corp. generates revenue through the production and sale of medical cannabis products under various brands in Canada, with the Canada cannabis segment handling domestic operations. The Rest-of-world cannabis segment sells cannabis products internationally where permitted, while the Storz & Bickel segment focuses on vaporizer sales. BioSteel contributes through consumer packaged goods like sports nutrition products. The company's primary buyers are consumers purchasing recreational and medical cannabis products in Canada, international customers in regions with legal cannabis frameworks, and retail partners for vaporizers and BioSteel products. Segments like Canada cannabis and Rest-of-world cannabis target adult recreational and medical markets, while Storz & Bickel serves users of vaporization devices and BioSteel targets health-conscious consumers. Canopy Growth's brands operate under distinct product lines: Canada cannabis offers a diverse range of cannabis, hemp, and cannabinoid-based products, Rest-of-world cannabis distributes similar products globally within legal boundaries, Storz & Bickel sells vaporizers, and BioSteel provides CPG items including sports nutrition, all contributing to the company's revenue streams. Canopy Growth is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Canopy Growth stock

R&D Spending per Employee of Canopy Growth is 870.20 CAD in 2025.

R&D Spending per Employee of Canopy Growth changed from 1,463.34 CAD to 870.20 CAD, representing a -40.53% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of R&D Spending per Employee Canopy Growth since 2006 – with annual values, charts, and detailed analysis.

R&D per employee shows the research and development investment allocated per employee. Higher values indicate innovation-focused companies.

R&D Spending per Employee's CAD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track R&D Spending per Employee's Canopy Growth historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Canopy Growth

All Key Metrics — Canopy Growth